Eton Pharmaceuticals Inc. (NASDAQ: ETON)
$3.63
+0.2900 ( +8.68% ) 204.9K
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
Market Data
Open
$3.63
Previous close
$3.34
Volume
204.9K
Market cap
$92.23M
Day range
$3.16 - $3.75
52 week range
$2.42 - $5.81
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | Feb 02, 2024 |
10-q | Quarterly Reports | 60 | Nov 09, 2023 |
8-k | 8K-related | 14 | Nov 09, 2023 |
8-k | 8K-related | 14 | Oct 04, 2023 |
10-q | Quarterly Reports | 60 | Aug 10, 2023 |
8-k | 8K-related | 13 | Aug 10, 2023 |
8-k | 8K-related | 12 | Jul 05, 2023 |